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Prurigo pigmentosa (PP) was originally
described 45 years ago, yet because of its vari-
able histopathological manifestations it remains
an under-recognized inflammatory dermatosis
clinically characterized by recurrent pruritic,
erythematous macules, urticarial papules and
papulovesicles that eventuate in symmetric retic-
ulated pigmentation.1 Although the majority
of cases have been reported in women of Asian
descent, it also has been described in various
ethnicities worldwide. Of the approximately 400
reported cases of PP, fewer than 10 have been
reported from the United States.1–7
Due to the relative rarity of this condition,
we present two cases from the United States
to illustrate the clinicopathological spectrum of
PP. Both patients were healthy young women
who presented with recurrent episodes of pru-
ritic erythematous macules and subsequently
developed urticarial plaques, papules and/or
papulovesicles which eventuated in reticulated
pigmentation. The clinical and histological find-
ings for these patients are summarized in Table 1.
Clinically PP presents as a recurrent intensely
pruritic, symmetrically distributed eruption
located on the neck, chest, upper back, lum-
bosacral region and abdomen, and more rarely,
the forehead or arms. To date, there are no
reports of mucous membrane involvement.5,7
The lesions tend to progress through several
stages of development, initially starting as
erythematous macules which then evolve to
urticarial papules and papulovesicles. Subse-
quently the lesions become crusted or scaly
and within a few weeks spontaneously resolve,
leaving behind reticulated pigmentation. Due
to the recurrent nature of the eruption, patients
often have multiple lesions at various stages of
development.1 The clinical differential diagno-
sis is broad, but the distribution of the lesions




Table 1. Clinicohistopathological presentations of patients 1 and 2
Patient 1 Patient 2
Clinical Findings
Ethnicity Palestinian descent Mexican descent
Duration 24-36 months 29-months
Anatomic location Chest (Figs. 1 and 3) Central chest and breast (Fig. 6), flank, sacrum,
buttock (Fig. 7) and focally on left elbow
Exacerbating factors Pregnancy Heat and exercise
Serological findings None Elevated WBC with left shift
Treatments Minocycline-improvement Topical steroids-minimal benefit.
Minocycline-resolution
Histopathological findings
Evolving lesion: Mild spongiosis, sparse perivascular infiltrate and
dermal edema. (Fig. 4)
Early lesions: Superficial dermal mixed inflammatory infiltrate
associated with neutrophilic spongiosis. (Fig. 2)
Epidermal spongiosis associated with a
perivascular lymphocytic infiltrate and focal
vacuolar degeneration.
Fully developed lesions Dense mixed dermal infiltrate associate with
combined balloon degeneration and spongiosis,
and clusters of necrotic keratinocytes. (Fig. 5)
Brisk vacuolar degeneration with numerous
apoptotic keratinocytes often concentrated near
acrosyringium. Superficial perivascular
lymphocytic infiltrate with increased
eosinophils. (Fig. 8)
Resolving/late lesions Mild spongiosis and a sparse perivascular
lymphocytic infiltrate.
Parakeratosis, focal apoptotic keratinocytes, and a
superficial perivascular lymphocytic infiltrate
containing melanophages. (Fig. 9)
Although the histopathological findings were
originally felt to be nonspecific, distinctive
histological features have now been identified
for each clinical stage.1,8–11,13,17 Early lesions
present as pruritic erythematous macules or
urticarial papules, and a biopsy from lesions
at this stage shows a sparse, perivascular and
interstitial, predominantly neutrophilic infil-
trate involving the superficial dermis with focal
epidermal exocytosis and variable papillary der-
mal edema. Fully developed lesions manifest
as excoriated papules, vesicles, and papulovesi-
cles which corresponds histologically to varying
degrees of spongiosis accompanied by balloon-
ing associated with epidermal necrosis and focal
collections of neutrophils. The dermal inflam-
matory infiltrate at this stage is denser, and often
mixed, with increased numbers of lymphocytes,
neutrophils and scattered eosinophils. In late
lesions, there is slight epidermal spongiosis and
focal parakeratosis associated with a mild super-
ficial perivascular lymphocytic infiltrate and
variable vacuolar degeneration. Often scattered
apoptotic keratinocytes and melanophages are
readily found. Therefore, the findings in any
given biopsy are reflective of the clinical stage of
the lesion, and represent only a single point on
an evolving continuum of clinical and histologic
features.
Depending on the stage of development,
the histopathological differential diagnosis
includes dermatitis herpetiformis, irritant con-
tact dermatitis, linear IgA disease, neutrophilic
dermatoses, erythema multiforme, adult onset
Still’s disease, as well as various spongiotic and
interface dermatitides.1,3,6 Although the reticu-
lated pigmentation can be clinically impressive,
histologically it is non-distinctive, showing only
a superficial perivascular lymphocytic infil-
trates associated pigment-laden macrophages,
which is indistinguishable from other inflamma-
tory dermatoses resulting in postinflammatory
hyperpigmentation.1 Therefore, accurate diag-
nosis requires detailed clinicopathological
correlation with attention to the dynamic clinical
and histopathological course of the disease.
The etiopathogenesis is unknown, but var-
ious hypothesizes have been postulated and
include friction, contact allergens, photosensi-
tivity, infectious agents, and metabolic disorders
such as diabetes mellitus, fasting, anorexia and
ketosis.1,3,5,9,11,14 To date, none have shown a
consistent causal relationship; however, symp-
toms are often exacerbated by hot weather
and/or sweating.1,5,13 There have been a few
case reports of PP associated with other diseases,
including autoimmune conditions, adult-onset
Still’s disease, atopy and pregnancy; however,
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Fig. 1. Erythematous, raised clustered and reticulated papules
on the chest of Patient 1.
Fig. 2. Biopsy specimen from a relatively “early” lesion of
Patient 1 showing diffuse epidermal spongiosis, lymphocytic
exocytosis, and subcorneal collections of neutrophils. The
upper dermal infiltrate is comprised of lymphocytes, neu-
trophils, and a few eosinophils.
these associations may merely be coincidental
rather than causative.1,5,12–15 Ilkovitch and Pat-
ton recently posited PP might represent an
inflammatory variant of confluent and reticu-
lated papillomatosis,16 but that hypothesis is not
supported histologically and those conditions
are quite distinct.
Most patients with PP experience spontaneous
resolution, followed by recurrent episodes of
exacerbations that can last months to years.1,9,11
The condition responds well to minocycline,
doxycycline and dapsone, presumably due to the
anti-inflammatory properties of these medica-
tions, as well as inhibition of the migration and
function of neutrophils.1,5,9,18,19 Yet notably, the
condition does not respond to treatment with
corticosteroids or anti-histamines.1,5 Lastly, there
has been one report of 2 patients who responded
well to weekly Jessner’s peels and irradiation with
an 830-nm light emitting diode.20
In conclusion, although PP is an uncommon
inflammatory dermatoses it can be readily rec-
ognized by its distinctive clinicopathological fea-
tures. Awareness of the dynamic changes that
occur over the course of the eruption is essential
to make an accurate diagnosis.
Fig. 3. Close-up view of Figure 1 which better
demonstrates the reticulate pattern and over-
lying focal scaling and crusting.
Fig. 4. Biopsy of an evolving lesion from
Patient 1 showing a normal basket weave stra-
tum corneum overlying a mildly spongiotic
epidermis.Within the superficial dermis there
is a sparse perivascular superficial lymphocytic
infiltrate associated with moderate papillary
dermal edema.
Fig. 5. A fully developed lesion from Patient
1 showing a moderately dense perivascular
and interstitial mixed inflammatory infiltrate
composed of lymphocytes, neutrophils and
rare eosinophils. The inflammatory infiltrate
extends into the overlying epidermis which
exhibits a combination of balloon degenera-
tion and spongiosis associated with clusters of
necrotic keratinocytes.
Fig. 6. Reticulated erythematous and hyper-
pigmented plaques on the chest of Patient 2.
Fig. 7. Patient 2 showing mature erythema-
tous papules on the left flank and right lateral
buttock as well as late hyperpigmented reticu-
lated plaques on the sacrum.
Fig. 8. Biopsy from a relatively “mature” ery-
thematous papule from the buttock of Patient
2. Massive spongiosis and lymphocytic exocy-
tosis has progressed to reticular degeneration
of the upper epidermis. The dermal infiltrate
is moderately dense and composed of perivas-
cular lymphocytes.
Fig. 9. A relatively “late” lesion from the
sacrum from Patient 2. There is paraker-
atosis, focal necrotic keratinocytes, vacuolar
interface alteration, and a predominantly
lymphocytic upper dermal infiltrate. In
such “late” lesions, upper dermal pigment
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